FLAG amends merger voting lock-up agreement: consent deadline extended to 15 business days after S-4 effective

Calidi Biotherapeutics, Inc.

Amendment to Voting and Lock-Up Agreement changes consent deadline from 2 to 15 business days after registration statement effective.
Amendment dated April 12, 2023; involves FLAG, Calidi Biotherapeutics, and significant Calidi shareholders.
No change to merger terms or other conditions; procedural extension to secure shareholder approvals.
Merger with Calidi was announced January 9, 2023; S-4 filed February 10, 2023.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Calidi Biotherapeutics, Inc. amended Voting and Lock-Up Agreement with certain holders of Calidi common stock (each, a "Significant Company Holder") (effective 2023-04-12).

Action: amendment
Agreement: merger
Counterparty: certain holders of Calidi common stock (each, a "Significant Company Holder")
Effective: 2023-04-12

Exact text from the filing

On April 12, 2023, FLAG, Calidi and each Significant Company Holder amended the Voting and Lock-Up Agreement to change the date by which each Significant Company Holder is required execute and deliver an irrevocable written consent approving (i) the Merger Agreement, Transaction Agreements and the Transactions (including the Merger) and (ii) any other matters necessary or appropriate in order to effect the Merger and the other transactions contemplated by the Merger Agreement to fifteen (15) business days following the time the registration statement filed in connection with the transaction is declared effective.

View on SEC.gov

Browse all material agreements →

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-100724

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.